Home Science Targeted therapy proves effective against aggressive rare blood cancerTechScienceTargeted therapy proves effective against aggressive rare blood cancerApril 24, 201942FacebookTwitterPinterestWhatsApp Clinical study treating BPDCN with tagraxofusp led to first FDA approval for the disease.